|
1
|
Ohgaki H: Epidemiology of brain tumors.
Methods Mol Biol. 472:323–342. 2009. View Article : Google Scholar
|
|
2
|
Ostrom QT, Gittleman H, Stetson L, Virk SM
and Barnholtz-Sloan JS: Epidemiology of gliomas. Cancer Treat Res.
163:1–14. 2015. View Article : Google Scholar
|
|
3
|
McNamara MG and Mason WP: Antiangiogenic
therapies in glioblastoma multiforme. Expert Rev Anticancer Ther.
12:643–654. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Vaupel P: Hypoxia and aggressive tumor
phenotype: Implications for therapy and prognosis. Oncologist.
13(Suppl 3): S21–S26. 2008. View Article : Google Scholar
|
|
5
|
Mongiardi MP: Angiogenesis and hypoxia in
glioblastoma: A focus on cancer stem cells. CNS Neurol Disord Drug
Targets. 11:878–883. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji RC: Hypoxia and lymphangiogenesis in
tumor microenvironment and metastasis. Cancer Lett. 346:6–16. 2014.
View Article : Google Scholar
|
|
7
|
Seftor RE, Hess AR, Seftor EA, Kirschmann
DA, Hardy KM, Margaryan NV and Hendrix MJ: Tumor cell vasculogenic
mimicry: From controversy to therapeutic promise. Am J Pathol.
181:1115–1125. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Qiao L, Liang N, Zhang J, Xie J, Liu F, Xu
D, Yu X and Tian Y: Advanced research on vasculogenic mimicry in
cancer. J Cell Mol Med. 19:315–326. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dong J, Zhao Y, Huang Q, Fei X, Diao Y,
Shen Y, Xiao H, Zhang T, Lan Q and Gu X: Glioma stem/progenitor
cells contribute to neovascularization via transdifferentiation.
Stem Cell Rev. 7:141–152. 2011. View Article : Google Scholar
|
|
10
|
Liu T, Sun B, Zhao X, Li Y, Gu Q, Dong X
and Liu F: OCT4 expression and vasculogenic mimicry formation
positively correlate with poor prognosis in human breast cancer.
Int J Mol Sci. 15:19634–19649. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Filipowicz W, Bhattacharyya SN and
Sonenberg N: Mechanisms of post-transcriptional regulation by
microRNAs: Are the answers in sight? Nat Rev Genet. 9:102–114.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang R, Pang B, Xin T, Guo H, Xing Y, Xu
S, Feng B, Liu B and Pang Q: Plasma miR-221/222 family as novel
descriptive and prognostic biomarkers for glioma. Mol Neurobiol.
Jan 31–2015.Epub ahead of print.
|
|
14
|
Dews M, Homayouni A, Yu D, Murphy D,
Sevignani C, Wentzel E, Furth EE, Lee WM, Enders GH, Mendell JT, et
al: Augmentation of tumor angiogenesis by a Myc-activated microRNA
cluster. Nat Genet. 38:1060–1065. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma L, Young J, Prabhala H, Pan E, Mestdagh
P, Muth D, Teruya-Feldstein J, Reinhardt F, Onder TT, Valastyan S,
et al: miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin
and cancer metastasis. Nat Cell Biol. 12:247–256. 2010.PubMed/NCBI
|
|
16
|
Zhao Z, Tan X, Zhao A, Zhu L, Yin B, Yuan
J, Qiang B and Peng X: microRNA-214-mediated UBC9 expression in
glioma. BMB Rep. 45:641–646. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li X, Ling N, Bai Y, Dong W, Hui GZ, Liu
D, Zhao J and Hu J: MiR-16-1 plays a role in reducing migration and
invasion of glioma cells. Anat Rec. 296:427–432. 2013. View Article : Google Scholar
|
|
18
|
Ying Z, Li Y, Wu J, Zhu X, Yang Y, Tian H,
Li W, Hu B, Cheng SY and Li M: Loss of miR-204 expression enhances
glioma migration and stem cell-like phenotype. Cancer Res.
73:990–999. 2013. View Article : Google Scholar :
|
|
19
|
Lee HK, Bier A, Cazacu S, Finniss S, Xiang
C, Twito H, Poisson LM, Mikkelsen T, Slavin S, Jacoby E, et al:
MicroRNA-145 is downregulated in glial tumors and regulates glioma
cell migration by targeting connective tissue growth factor. PLoS
One. 8:e546522013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Gao R, Cai C, Gan J, Yang X, Shuang Z, Liu
M, Li S and Tang H: miR-1236 down-regulates alpha-fetoprotein, thus
causing PTEN accumulation, which inhibits the PI3K/Akt pathway and
malignant phenotype in hepatoma cells. Oncotarget. 6:6014–6028.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Song Y, Mu L, Han X, Li Q, Dong B, Li H
and Liu X: MicroRNA-9 inhibits vasculogenic mimicry of glioma cell
lines by suppressing Stathmin expression. J Neurooncol.
115:381–390. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu N, Zhao X, Liu M, Liu H, Yao W, Zhang
Y, Cao S and Lin X: Role of microRNA-26b in glioma development and
its mediated regulation on EphA2. PLoS One. 6:e162642011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yan S, Han X, Xue H, Zhang P, Guo X, Li T,
Guo X, Yuan G, Deng L and Li G: Let-7f inhibits glioma cell
proliferation, migration, and invasion by targeting periostin. J
Cell Biochem. 116:1680–1692. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meister G, Landthaler M, Dorsett Y and
Tuschl T: Sequence- specific inhibition of microRNA- and
siRNA-induced RNA silencing. RNA. 10:544–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Hutvágner G, Simard MJ, Mello CC and
Zamore PD: Sequence-specific inhibition of small RNA function. PLoS
Biol. 2:e982004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kim DH and Rossi JJ: Strategies for
silencing human disease using RNA interference. Nat Rev Genet.
8:173–184. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yan W, Li R, Liu Y, Yang P, Wang Z, Zhang
C, Bao Z, Zhang W, You Y and Jiang T: MicroRNA expression patterns
in the malignant progression of gliomas and a 5-microRNA signature
for prognosis. Oncotarget. 5:12908–12915. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Auffinger B, Thaci B, Ahmed A, Ulasov I
and Lesniak MS: MicroRNA targeting as a therapeutic strategy
against glioma. Curr Mol Med. 13:535–542. 2013. View Article : Google Scholar
|
|
29
|
Yang CH, Yue J, Pfeffer SR, Fan M, Paulus
E, Hosni-Ahmed A, Sims M, Qayyum S, Davidoff AM, Handorf CR, et al:
MicroRNA-21 promotes glioblastoma tumorigenesis by down-regulating
insulin-like growth factor-binding protein-3 (IGFBP3). J Biol Chem.
289:25079–25087. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Barbano R, Palumbo O, Pasculli B, Galasso
M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P,
et al: A miRNA signature for defining aggressive phenotype and
prognosis in gliomas. PLoS One. 9:e1089502014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lai NS, Wu DG, Fang XG, Lin YC, Chen SS,
Li ZB and Xu SS: Serum microRNA-210 as a potential noninvasive
biomarker for the diagnosis and prognosis of glioma. Br J Cancer.
112:1241–1246. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Que T, Song Y, Liu Z, Zheng S, Long H, Li
Z, Liu Y, Wang G, Liu Y, Zhou J, et al: Decreased miRNA-637 is an
unfavorable prognosis marker and promotes glioma cell growth,
migration and invasion via direct targeting Akt1. Oncogene.
34:4952–4963. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Harris AL: Hypoxia - a key regulatory
factor in tumour growth. Nat Rev Cancer. 2:38–47. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Fan YL, Zheng M, Tang YL and Liang XH: A
new perspective of vasculogenic mimicry: EMT and cancer stem cells
(Review). Oncol Lett. 6:1174–1180. 2013.PubMed/NCBI
|
|
35
|
Smith SJ, Ward JH, Tan C, Grundy RG and
Rahman R: Endothelial-like malignant glioma cells in dynamic three
dimensional culture identifies a role for VEGF and FGFR in a
tumor-derived angiogenic response. Oncotarget. 6:22191–22205. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jhaveri N, Chen TC and Hofman FM: Tumor
vasculature and glioma stem cells: Contributions to glioma
progression. Cancer Lett. Dec 16–2014.(epub ahead of print). pii:
S0304-3835(14)00783-6. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Yue WY and Chen ZP: Does vasculogenic
mimicry exist in astrocytoma? J Histochem Cytochem. 53:997–1002.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Mao JM, Liu J, Guo G, Mao XG and Li CX:
Glioblastoma vasculogenic mimicry: Signaling pathways progression
and potential anti-angiogenesis targets. Biomark Res. 3:2015.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Cardama GA, Gonzalez N, Ciarlantini M,
Gandolfi Donadío L, Comin MJ, Alonso DF, Menna PL and Gomez DE:
Proapoptotic and antiinvasive activity of Rac1 small molecule
inhibitors on malignant glioma cells. Onco Targets Ther.
7:2021–2033. 2014.PubMed/NCBI
|
|
40
|
Könnecke H and Bechmann I: The role of
microglia and matrix metalloproteinases involvement in
neuroinflammation and gliomas. Clin Dev Immunol. 2013:9141042013.
View Article : Google Scholar : PubMed/NCBI
|
